Your browser doesn't support javascript.
loading
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Ellingson, Benjamin M; Gerstner, Elizabeth R; Lassman, Andrew B; Chung, Caroline; Colman, Howard; Cole, Patricia E; Leung, David; Allen, Joshua E; Ahluwalia, Manmeet S; Boxerman, Jerrold; Brown, Matthew; Goldin, Jonathan; Nduom, Edjah; Hassan, Islam; Gilbert, Mark R; Mellinghoff, Ingo K; Weller, Michael; Chang, Susan; Arons, David; Meehan, Clair; Selig, Wendy; Tanner, Kirk; Alfred Yung, W K; van den Bent, Martin; Wen, Patrick Y; Cloughesy, Timothy F.
Affiliation
  • Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Gerstner ER; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Lassman AB; Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, New York, USA.
  • Chung C; University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Cole PE; Bayer Pharmaceuticals, Whippany, New Jersey, USA.
  • Leung D; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Allen JE; Chimerix, Durham, North California, USA.
  • Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.
  • Boxerman J; Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Brown M; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Goldin J; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Nduom E; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hassan I; Servier Pharmaceuticals, Boston, Massachusetts, USA.
  • Gilbert MR; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Mellinghoff IK; Department of Neurology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Weller M; Department of Neurology, University Hospital and University of Zurich, Switzerland.
  • Chang S; Division of Neuro-Oncology, University of California San Francisco, San Francisco, California, USA.
  • Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Selig W; WSCollaborative, LLC, McLean, Virginia, USA.
  • Tanner K; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Alfred Yung WK; University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Wen PY; Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA.
  • Cloughesy TF; UCLA Neuro Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Neuro Oncol ; 24(8): 1219-1229, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35380705

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido